Iris Gluck

5.0k citations
24 papers · 3.6k · 3 hit papers · h-index 14

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • CAR-T cell therapy research

Papers in

    • Head and Neck Cancer Studies 8
    • Cancer Immunotherapy and Biomarkers 2
    • Cancer-related Molecular Pathways 1

Iris Gluck

24 papers receiving 3.5k citations

Iris Gluck's Hit Papers

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial 2024 · 134 citations
1340+2+5Years since publication50010001.5k2.0k

Peers

Iris Gluck
Comparison fields: 5 of 83
  • Otorhinolaryngology 1.2k
  • Oncology 1.6k
  • Immunology 432
  • Pulmonary and Respiratory Medicine 613
  • Cancer Research 255
Replace Yungpo Bernard Su with:
Yungpo Bernard Su United States
Milan Vošmik Czechia
Priscilla Baetiong Caguioa Philippines
Orit Gutfeld Israel
Meltem Ekenel Türkiye
Niels Gyldenkerne Denmark
Nicholas Paul Campbell United States
Ulisses Ribaldo Nicolau Brazil
Nobuya Monden Japan
Danko Martincic United States
Iris Gluck relative to Yungpo Bernard Su United States Yungpo Bernard Su's profile →
Citations per field
00.5×1.5×1.8×
Yungpo Bernard Su · 1×
Citations per year

Countries citing papers authored by Iris Gluck

Since Specialization
Citations

This map shows the geographic impact of Iris Gluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Gluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Gluck more than expected).

Fields of papers citing papers by Iris Gluck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Gluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Gluck. The network helps show where Iris Gluck may publish in the future.

Co-authors

The 25 scholars most cited alongside Iris Gluck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Gluck Line = papers co-authored together Iris Gluck links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Hit paper breakdown →
20192460
2
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Hit paper breakdown →
2018368
3
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Hit paper breakdown →
2024134
4 2009110
5 202276
6 200655
7 201055
8 201848
9 200847
10 201242
11 200928
12 201426
13 202024
14 201318
15 201814
16 201012
17 201712
18 199811
19 20099
20 20094

About Iris Gluck

Iris Gluck is a scholar working on Otorhinolaryngology, Oncology, Speech and Hearing, Cancer Research and Nutrition and Dietetics, having authored 24 papers that have together received 3.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (8 papers), Dysphagia Assessment and Management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Clinical Nutrition and Gastroenterology (1 paper), Cancer Genomics and Diagnostics (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Cancer-related Molecular Pathways (1 paper) and Nonmelanoma Skin Cancer Studies (1 paper). The work is most often cited by research in Otorhinolaryngology (1.2k citations), Oncology (1.6k citations), Immunology (432 citations), Pulmonary and Respiratory Medicine (613 citations) and Cancer Research (255 citations). Iris Gluck has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Douglas Brian Chepeha, Avraham Eisbruch, Ranee Mehra, Joseph P. Eder, Jonathan D. Cheng, Jared Weiss, Shilpa Gupta, Makoto Tahara, Laura Q.M. Chow and Kei Muro. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Otolaryngology, Cancer Immunology Research, American Journal of Hypertension and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact